neuraxpharm has acquired 4 companies of its own, including 4 in the last 5 years. It has also divested 1 asset.
neuraxpharm has acquired in 4 countries. The Company’s most targeted sectors include life science (75%) and medical products (25%).
Elisabeth-Selbert-Str. 23,
Langenfeld,
40764
Germany,
+49 02173 10600
www.neuraxpharm.de
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2023-04-27 |
Inke · Life Science
Castellbisbal, Spain · www.inke.es Inke is a developer and manufacturer of the quality active pharmaceutical ingredients (APIs) with complex synthesis processes, mainly for use in respiratory therapies. Inke is a key supplier to major generic and branded companies worldwide, having twelve respiratory APIs for inhalation in its portfolio and distributing its products to more than 40 countries including Europe, the US, Japan, Korea, China and Turkey. Inke was founded in 1980 and is based in Castellbisbal, Spain. |
- | Divestiture |
Keensight Capital
PE
|
neuraxpharm
|
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
